Allmed Solutions Ltd (ALMD) - Total Liabilities
Based on the latest financial reports, Allmed Solutions Ltd (ALMD) has total liabilities worth ILA3.48 Million ILA (≈ $9.32K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore ALMD net asset momentum to track the company's year-over-year net asset growth rate.
Allmed Solutions Ltd - Total Liabilities Trend (2008–2025)
This chart illustrates how Allmed Solutions Ltd's total liabilities have evolved over time, based on quarterly financial data. See ALMD cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Allmed Solutions Ltd Competitors by Total Liabilities
The table below lists competitors of Allmed Solutions Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shanghai Broadband Technology Co Ltd
SHG:600608
|
China | CN¥61.81 Million |
|
Newbury Pharmaceuticals AB
ST:NEWBRY
|
Sweden | Skr45.96 Million |
|
Alice QUEEN Ltd
AU:AQX
|
Australia | AU$1.48 Million |
|
Aumake Ltd
AU:AUK
|
Australia | AU$4.53 Million |
|
RS Public Company Limited
BK:RS
|
Thailand | ฿5.35 Billion |
|
Pharmacielo Ltd
V:PCLO
|
Canada | CA$23.57 Million |
|
Intanwijaya Internasional Tbk
JK:INCI
|
Indonesia | Rp73.38 Billion |
|
Amtel Holdings Bhd
KLSE:7031
|
Malaysia | RM14.90 Million |
Liability Composition Analysis (2008–2025)
This chart breaks down Allmed Solutions Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Allmed Solutions Ltd.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 10.31 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Allmed Solutions Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Allmed Solutions Ltd (2008–2025)
The table below shows the annual total liabilities of Allmed Solutions Ltd from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ILA3.48 Million ≈ $9.32K |
+25.23% |
| 2024-12-31 | ILA2.77 Million ≈ $7.44K |
-13.15% |
| 2023-12-31 | ILA3.19 Million ≈ $8.57K |
-16.21% |
| 2022-12-31 | ILA3.81 Million ≈ $10.22K |
+53.56% |
| 2021-12-31 | ILA2.48 Million ≈ $6.66K |
-67.27% |
| 2020-12-31 | ILA7.59 Million ≈ $20.34K |
-28.59% |
| 2019-12-31 | ILA10.62 Million ≈ $28.49K |
+3.60% |
| 2018-12-31 | ILA10.26 Million ≈ $27.50K |
-21.69% |
| 2017-12-31 | ILA13.10 Million ≈ $35.11K |
-6.64% |
| 2016-12-31 | ILA14.03 Million ≈ $37.61K |
+18.61% |
| 2015-12-31 | ILA11.83 Million ≈ $31.71K |
-6.78% |
| 2014-12-31 | ILA12.69 Million ≈ $34.01K |
-5.20% |
| 2013-12-31 | ILA13.38 Million ≈ $35.88K |
+1.12% |
| 2012-12-31 | ILA13.23 Million ≈ $35.48K |
+83.87% |
| 2011-12-31 | ILA7.20 Million ≈ $19.30K |
-24.14% |
| 2010-12-31 | ILA9.49 Million ≈ $25.44K |
+1364.35% |
| 2009-12-31 | ILA648.00K ≈ $1.74K |
-49.96% |
| 2008-12-31 | ILA1.29 Million ≈ $3.47K |
-- |
About Allmed Solutions Ltd
Allmed Solutions Ltd develops, manufactures, and markets minimally invasive products in various medical disciplines in Israel and internationally. The company offers drugs, biological products, and medical devices; and ProCatid system, a distal embolic protection system comprised of an independent filter unit that can be delivered, locked, and deployed on any commercially marketed guide wires. It… Read more